Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

H. Lee Moffitt Cancer Center and Research Institute, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

ERA-923 in Treating Postmenopausal Women With Metastatic Breast Cancer

Phase 2

Conditions: Breast Cancer

First Posted Date: 2004-04-02

Last Posted Date: 2013-11-06

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Registration Number: NCT00006369

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Phase 2

Terminated

Conditions: Prostate Cancer

Interventions: Drug: aminoglutethimide
Drug: ketoconazole
Drug: therapeutic hydrocortisone

First Posted Date: 2004-04-02

Last Posted Date: 2012-09-27

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 2

Registration Number: NCT00006371

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

R115777 in Treating Patients With Advanced Bladder Cancer

Phase 2

Completed

Conditions: Bladder Cancer
Transitional Cell Cancer of the Renal Pelvis and Ureter

First Posted Date: 2004-04-02

Last Posted Date: 2013-12-04

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Registration Number: NCT00006376

Locations: 🇺🇸
UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States
🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Women With Metastatic Breast Cancer

Phase 2

Terminated

Conditions: Breast Cancer

First Posted Date: 2004-04-02

Last Posted Date: 2012-12-11

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Registration Number: NCT00006032

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Comparison of Two Types of Biopsy in Patients With Breast Lesions

Not Applicable

Completed

Conditions: Breast Cancer

First Posted Date: 2004-04-02

Last Posted Date: 2012-09-26

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 117

Registration Number: NCT00006031

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Phase 1

Completed

Conditions: Melanoma (Skin)

First Posted Date: 2004-04-02

Last Posted Date: 2012-09-25

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 24

Registration Number: NCT00005615

Locations: 🇺🇸
Sylvester Cancer Center, University of Miami, Miami, Florida, United States
🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Women With Breast Cancer

Phase 2

Completed

Conditions: Breast Cancer

Interventions: Drug: Carboplatin
Drug: Cyclophosphamide
Drug: Thiotepa

First Posted Date: 2004-04-02

Last Posted Date: 2012-10-26

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 209

Registration Number: NCT00005798

Locations: 🇺🇸
Halifax Medical Center, Daytona Beach, Florida, United States
🇺🇸
Florida Cancer Specialists, Fort Myers, Florida, United States
🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

CP-609,754 in Treating Patients With Advanced Solid Tumors

Phase 1

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

First Posted Date: 2004-03-16

Last Posted Date: 2013-12-19

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Registration Number: NCT00006085

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Therapy With Oral 9-Nitrocamptothecin & Oral Etoposide

Phase 1

Completed

Conditions: Unspecified Adult Solid Tumor, Protocol Specific

Interventions: Drug: Oral Etoposide
Drug: Oral 9-Nitrocamptothecin

First Posted Date: 2004-02-12

Last Posted Date: 2012-09-26

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 44

Registration Number: NCT00006047

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

Combination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma

Phase 1

Completed

Conditions: Plasma Cell Neoplasm
Multiple Myeloma

Interventions: Drug: etoposide phosphate
Drug: melphalan
Drug: topotecan
Procedure: Autologous Stem Cell Rescue

First Posted Date: 2004-02-02

Last Posted Date: 2019-11-08

Lead Sponsor: H. Lee Moffitt Cancer Center and Research Institute

Target Recruit Count: 131

Registration Number: NCT00005792

Locations: 🇺🇸
H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy